ГоловнаArchive of numbers2020Volume 28, issue 3 (104)Gut microbiota and autoimmune diseases (Literature review)
Title of the article Gut microbiota and autoimmune diseases (Literature review)
Authors Tereshchenko Liudmyla
Voloshyna Natalia
In the section LITERATURE REVIEW
Year 2020 Issue Volume 28, issue 3 (104) Pages 63-69
Type of article Scientific article Index UDK 612 017-06-052:579 61 Index BBK -
Abstract DOI: https://doi.org/10.36927/2079-0325-V28-is3-2020-10

 Autoimmune diseases are chronic progressive processes associated with dysfunction of the central and peripheral structures of the nervous system. The understanding of the processes taking place inside the body has changed significantly thanks to modern technologies, which made it possible to identify the close relationship of the intestine with the nervous, endocrine, and immune systems of a person. It is believed that the majority of chronic diseases of multifactorial nature are based on changes in the species diversity of the gut microbiota, which leads to irreversible damage to the homeostasis of the microorganism. Dysfunction associated with changes in the composition, diversity and metabolic activity of the gut microbiota leads to the development of inflammation and some chronic diseases. Many scientific authors conducted data analysis of the role of the gut microbiota in the development of autoimmune diseases and the possible ways of correction. A number of issues concerning the interaction of macro- and microorganisms are being actively studied and require further clarification. Changes in the immune status of the human body, which occur during the restructuring of the gut microbiome in patients with autoimmune diseases, are important. Compensation of nutritional imbalance, gut microbiota, as well as physical activity adequate for age and living conditions, allows providing energy homeostasis and is a promising direction for preventing the development and reducing the rate of progression of autoimmune diseases.
Key words gut microbiota, autoimmune diseases, immune dysfunction, homeostasis, probiotics, lifestyle modification
Access to full text version of the article pdf download
Bibliography 1 Grinevich V. B., Zaharchenko M. M. Sovremennye predstavleniya o znachenii kishechnogo mikrobiocenoza cheloveka. Sposoby korrekcii ego narushenij // Novye Sankt-Peterburgskie vrachebnye vedomosti. 2003. № 3. S. 13—20.
2. Computational profiling of the gut-brain axis: microflora dysbiosis insights to neurological disorders / Dovrolis N., Kolios G., Spyrou G. M., Maroulakou I. // Briefings in Bioinformatics. 2017. Nov. 27. Vol. 20, Issue 3. P. 825—841. DOI: https://doi.org/10.1093/bib/bbx154.
3. The gut-brain axis: Interactions between enteric microbiota central and enteric nervous systems / M. Carabotti, A. Scirocco, M. A. Maselli, C. Severi // Ann Gastroenterol. 2015. No. 28 (2). Р. 203—209. PMID: 25830558.
4. Microbiota dysbiosis controls the neuroinflammatory response after stroke / V. Singh, S. Roth, G. Llovera [et al.] // J. Neurosci. 2016. Jul 13; 36 (28): 7428—7440. DOI: 10.1523/JNEUROSCI.1114-16.2016.
5. Lederberg J. and McCray A. ‘Ome Sweet ‘Omics — A Genealogical Treasury of Words // The Scientist. 2001. No. 15 (7). Р. 8. URL: https://lhncbc.nlm.nih.gov/publication/lhncbc-2001-047.
6. Mechnikov I. I. Etyudy optimizma. 2-e izd. M., 1909. 282 s., il. (na fr. yaz. 1907).
7. The treatment-naive microbiome in new-onset Crohn’s disease / D. Gevers, S. Kugathasan, L. A. Denson [et al.] // Cell Host & Microbe. 2014. Vol. 15, Issue 3. Р. 382—392. DOI: https://doi.org/10.1016/j.chom.2014.02.005.
8. Beloborodova N. V. Metabolizm mikrobioty pri kriticheskih sostoyaniyah (obzor i postulaty) // Obshaya reanimatologiya. 2019. T. 15, № 6. S. 62—79. DOI: https://doi.org/10.15360/1813-9779-2019-6-62-79.
9. Berg R. D. The indigenous gastrointestinal microflora // Trend Microbial. 1996. No. 4 (11). Р. 430—435. DOI: 10.1016/0966-842x(96)10057-3.
10. Kelly D., Mudler I. E. Microbiome and immunological interaction // Nutr. Rew. 2012. No. 70. С. 18—30. DOI: 10.1111/j.1753-4887.2012.00498.
11. Structure, function and diversity of the healthy human microbiome. Human Microbiome Project Consortium / Nature. 2012 Jun 13. 486 (7402). P. 207-214. DOI: 10.1038/nature11234.
12. Mandal R. S., Saha S., Das S. Metagenomic surveys of gut microbiota // Genomics, Proteomics & Bioinformatics. 2015. Vol. 13, Issue 3. Р. 148—158. DOI: 10.1016/j.gpb.2015.02.005.
13. Iannitti T., Palmieri B. Therapeutical use of probiotic formulations in clinical practice // Clin. Nutr. 2010 Dec. No. 29 (6). С. 701—725. DOI: 10.1016/j.clnu.2010.05.004.
14. Host-gut microbiota metabolic interactions / J. K. Nicholson, E. Holmes, J. Kinross [et al.] // Science. June 2012. 336 (6086): 1262—7. DOI: 10.1126/science.1223813.
15. Oden M. Rody i evolyuciya Homo Sapiens (Childbirth and the evolution of Homo sapiens, 2014) / per. s angl. M. : Izd-vo Nazarovyh, 2016. 200 s. URL: https://www.livelib.ru/book/1001263854-rody-i-evolyutsiya-homo-sapiens-mishel-oden.
16. Prostor L. M. The Human Microbiome Project in 2011 and beyond // Cell Host & Microbe. 2011. Vol. 10. Issue 4. Р. 287—291. DOI: 10.1016/j.chom.2011.10.001.
17. Tyakht A. V., Kostryukova E. S., Govorun V. M. Human gut microbiota community structures in urban and rural populations in Russia // Nature Communications. 2013. Vol. 4, Article number: 2469. DOI: 10.1038/ncomms3469.
18. Chernevskaya E. A., Beloborodova N. V. Mikrobiota kishechnika pri kriticheskih sostoyaniyah (obzor) // Obshaya reanimatologiya. 2018. T. 14. № 5. S. 96—119. DOI: https://doi.org/10.15360/1813-9779-2018-5-96-119.
19. Qin J., Li R., Wang J. A human gut microbial gene catalogue established by metagenomic sequencing // Nature. 2010. Vol. 464. P. 59—65. DOI: 10.1038/nature08821.
20. An obesity-associated gut microbiome with increased capacity for energy harvest / P. J. Turnbaugh, R. E. Ley, M. A. Mahowald [et al.] // Nature. 2006. Vol. 444. Р. 1027—1031. DOI: 10.1038/nature05414.
21. The Firmicutes/Bacteroides ratio of the human microbiota changes with age / D. Mariat, O. Firmesse, F. Levenez [et al.] // BMC Microbiology. 2009. Vol. 9. Article number: 123. DOI: https://doi.org/10.1186/1471-2180-9-123.
22. Rajilić-Stojanović M., Smidt H., De Vos W. M. Diversity of the human gastrointestinal tract microbiota revisited // Environmental Microbiology. 2007. Vol. 9, Issue 9.P. 2125—2136. DOI: https://doi.org/10.1111/j.1462-2920.2007.01369.x.
23. Gut microbiota in health and disease / I. Serikov, S. L. Russell, L. C. M. Antunes and B. B. Finlay // Physiol Rev. 2010. Vol. 90, No 3. P. 859—904. DOI: 10.1152/physrev.00045.2009.
24. Cho I. & Blaser M. J. The human microbiome: at the interface of health and disease // Nature Reviews Genetics. 2012. Vol. 13. С. 260—270. DOI: 10.1038/nrg3182.
25. A metagenomic insight into our gut’s microbiome / P. Lepage, M. C. Leclerc, M. Joossens [et al.] // Gut. 2013 Jan; 62 (1): 146—58. DOI: 10.1136/gutjnl-2011-301805. Epub 2012 Apr 23. DOI: 10.1136/gutjnl-2011-301805.
26. An obesity-associated gut microbiome with increased capacity for energy harvest / P. J. Turnbaugh, R. E. Ley, M. A. Mahowald [et al.] Nature. 2006. Dec 21; 444 (7122): Р. 1027—31. DOI: 10.1038/nature05414.
27.Baryshnikova N. V. Geneticheskie osobennosti Helicobacter pylori u bolnyh yazvennoj boleznyu dvenadcatiperstnoj kishki // Eksperimentalnaya i klinicheskaya gastroenterologiya. 2009. № 7. S. 80—82. URL: eLIBRARY ID: 33601124.
28. The microbiome of the urinary tract — a role beyond infection / S. A. Whiteside, H. Razvi, S. Dave [et al.] // Nature Reviews Urology. 2015. No. 12. Р. 81—90. DOI: 10.1038/nrurol.2014.361. The microbiome of the urinary tract—a role beyond infection
29. Ley R. E., Peterson D. A., Gordon J. I. Ecological and evolutionary forces chaping microbial diversity in the human intestine // Cell. 2006 Feb 24. Vol. 124 (4). Р. 837-848. DOI: 10.1016/j.cell.2006.02.017.
30. Martínez I., Muller C. E., Walter J. Long-term temporal analysis of the human fecal microbiota revealed a stable core of dominant bacterial species // PLoS One. 2013 Jul 16; 8 (7): e69621. DOI: 10.1371/journal.pone.0069621.
31. The human urine virome in association with urinary tract infections / T. M. Santiago-Rodriguez, M. Ly, N. Bonilla and D. T. Pride // Front. Microbiol. 2015. Jan 23; 6: 14. DOI: https://doi.org/10.3389/fmicb.2015.00014.
32. Ackerman A. L., Underhill D. M. The mycobiome of the human urinary tract: potential roles for fungi in urology // Ann Transl Med. 2017 Jan; 5 (2): P. 31. DOI: 10.21037/atm.2016.12.69.
33. The function of our microbiota: who is out there and what do they do? / N. Oltmann, H. Smidt, W. M. de Vos, C. Belzer // Front Cell Infect Microbiol. 2012. Vol. 9, no. 2. Р. 104. DOI: 10.3389/fcimb.2012.00104.
34.Makarova S. G., Broeva M. I. Vliyanie razlichnyh faktorov na rannie etapy formirovaniya kishechnoj mikrobioty // Pediatricheskaya farmakologiya. 2016. T. 13, № 3. S. 270—282. DOI: https://doi.org/10.15690/pf.v13i3.1577
35. A core gut microbiome in obese and lean twins / P. J. Turnbaugh, M. Hamady, T. Yatsunenko [et al.] // Nature. 2009 Jan 22; 457 (7228): 480—484. DOI: 10.1038/nature07540.
36. Dethlefsen L., McFall-Ngai M. & Relman D. A. An ecological and evolutionary perspective on human–microbe mutualism and disease // Nature. 2007 Oct. Vol. 449 (7164). P. 811—8. DOI: 10.1038/nature06245.
37. Everard A., Cani P. D. Gut microbiota and GLP-1 // Reviews in Endocrine and Metabolic Disorders. 2014 Sep. Vol. 15 (3). Р. 189—196. DOI: 10.1007/s11154-014-9288-6.
38. Ohnmacht C. Microbiota, regulatory T cell subsets, and allergic disorders // Allergo Journal International. 2016. Vol. 25 (5). Р. 114—123. DOI: 10.1007/s40629-016-0118-0.
39. Oshima T. & Miwa H. Gastrointestinal mucosal barrier function and diseases // J Gastroenterology. 2016. Vol. 51 (8). Р. 768—778. DOI: 10.1007/s00535-016-1207-z.
40. Farré R., Vicario M. Abnormal Barrier Function in Gastrointestinal Disorders // Handb Exp Pharmacol. 2017. Vol. 239. P. 193—217. DOI: 10.1007/164_2016_107.
41. Pathobiont release from dysbiotic gut microbiota biofilms in intestinal inflammatory diseases: a role for iron? / A. G. Buret, J.-P. Motta, T. Allain [et al.] // J Biomed. Sci. 2019. Vol. 26 (1). Р. 1. DOI: 10.1186/s12929-018-0495-4.
42. The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations / C. Martínez, M. Vicario, L. Ramos [et al.] // Am J Gastroenterol. 2012 May. 107 (5). Р. 736—746. DOI: 10.1038/ajg.2011.472.
43.Markov A. G., Veshnyakova A. Yu., Krug S., Milac S. Ekspressiya belkov plotnyh kontaktov v epitelii tonkoj kishki krysy // Rossijskij fiziologicheskij zhurnal im. I. M. Sechenova. 2007. T. 93. № 9. S. 1043—1054. URL: https://www.elibrary.ru/item.asp?id=9603019.
44.Enteropatiya s narusheniem membrannogo pishevareniya / A. I. Parfenov, N. I. Belostockij, S. R. Dbar [i dr.] // Effektivnaya farmakoterapiya. 2018. № 16 (2). C. 20—27. eLIBRARY ID: 35192164. 45. Noble E. E., Hsu T. M., and Kanoski S. E. Gut to brain dysbiosis: mechanisms linking western diet consumption, the microbiome and cognitive impairment // Front. Behav. Neurosci. 2017. No. 11. Р. 9. DOI: https://doi.org/10.3389/fnbeh.2017.00009.
46. The Gut Microflora and its Metabolites Regulate the Molecular Crosstalk between Diabetes and Neurodegeneration / S. Westfal, N. Lomis, S. P. Singh [et al.] // J Diabetes Metab. Vol. 6. Issue 8 Р. 1—16. DOI: 10.4172/2155-6156.1000557.
47. Rol mikrobioty v formirovanii autoimmunnogo vospaleniya pri vospalitelnyh zabolevaniyah kishechnika / Danilova N. A., Valeeva A. R., Abdulhakov S. R. [i dr.] // Eksperimentalnaya i klinicheskaya gastroenterologiya. 2017. № 7 (143). S. 121—125. URL: https://www.elibrary.ru/item.asp?id=30507329
48. POH-1 deubiquitinates pro-interleukin-1β restricts inflammasome activity / Li Zhang, Yun Liu, Boshi Wang [et al.] // Nat Commun. 2018 Oct 12; 9 (1): 4225. DOI: 10.1038/s41467-018-06455-z.
49. Cassel S. L., Sutterwala F. S. Sterile inflammatory responses mediated by the NLRP3 inflammasome // Eur J Immunol. 2010 Mar. No. 40 (3). Р. 607—611. DOI: 10.1002/eji.200940207.
50. Caspi R. R. A look at autoimmunity and inflammation in the eye // J Clin Invest. 2010. 120: 3073—83. DOI: https://doi.org/10.1167/iovs.15-17280.
51. Microbiota-Dependent Activation of an Autoreactive T Cell Receptor Provokes Autoimmunity in an Immunologically Privileged Site / R. Horai, C. R. Zárate-Bladés, P. Dillenburg-Pilla [et al.] // Immunity. 2015. Aug 18. 43 (2). Р. 343—353. DOI: 10.1016/j.immuni.2015.07.014.
52. Sostav mikrobioty kishechnika i populyacij cirkuliruyushih Th-kletok u pacientov s rasseyannym sklerozom / I. N. Abdurasulova, E. A. Tarasova, I. V. Kudryavcev [i dr.] // Infekciya i immunitet. 2019. T. 9. № 3—4. R. 504—522. https://doi.org/10.15789/2220-7619-2019-3-4-504-522.
53. Disbioz (disbakterioz) kishechnika: sovremennoe sostoyanie problemy, kompleksnaya diagnostika i lechebnaya korrekciya / Ardatskaya M. D., Belmer S. V., Dobrica V. P. [i dr.] // Eksperimentalnaya i klinicheskaya gastroenterologiya. 2005. № 5. S. 13—50.
54. Type 1 interferons and microbial metabolites of tryptophan modulate astrocyte and Central nervous System inflammation via the aryl hydrocarbon receptor / W. Rothammer, I. D. Mascanfroni, L. Bunse [et al.] // Nature medicine. 2016 Jun; 22 (6): 586—597.DOI: 10.1038/nm.4106.
55. Gut bacteria from multiple sclerosis patients modulate human T-cells and exacerbate symptoms in mouse models / E. Cekanaviciute, B. B. Yoo, T. F. Runia [et al.] // Proc Natl Acad Sci. USA. 2017 Oct 3. Vol. 114 (40). P. 10713—10718. DOI: 10.1073/pnas.1711235114.
56. Livshic Karlos, Zaharova I. N., Dmitrieva Yu. A. Vliyanie kishechnogo mikrobioma v norme i patologii na zdorove cheloveka // Medicinskij Sovet. 2017. № 1. S. 155—159. DOI: https://doi.org/10.21518/2079-701X-2017-1-155-159.
57.Munblit D. B., Korsunskij I. A. Pro- i prebiotiki v profilaktike lecheniya allergicheskih zabolevanij // RMZh. 2016. № 6 (1). S. 354—357.
58.Grinevich V. B., Sas E. I., Efimov O. I., Sherbina N. N. Korrekciya disbioza kishechnika — faktor preodoleniya insulinorezistentnosti // Rossijskij zhurnal gastroenterologii, gepatologii, koloproktologii. 2009. № 19 (1, Pril. 33). S. 90—91.
59.Bureva S. A. Neobhodimost primeneniya metabiotikov v kompleksnoj terapii bolnyh s kandidozom organov pishevogo trakta // RMZh. 2015. № 19. S. 1179.
60. Exercise Modifies the Gut Microbiota with Positive Health Effect / V. Monda, I. Villano, A. Messina [et al.] // Oxid Med Cell Longev. 2017. No. 383. Р. 1972. DOI: 10.1155/2017/3831972.